High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor

Ann N Y Acad Sci. 1993 Nov 30:698:389-97. doi: 10.1111/j.1749-6632.1993.tb17231.x.

Authors

M Venturini¹, L Del Mastro, A Ardizzoni, M R Sertoli, G L Mariani, M C Pennucci, O Garrone, S Silvestro, G F Addamo, P Queirolo, et al.

Affiliation

¹ Medical Oncology Department, Istituto Nazionale per la Ricerca sul Cancro (IST), Genova, Italy.

PMID: 8279779
DOI: 10.1111/j.1749-6632.1993.tb17231.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Colony-Stimulating Factors / therapeutic use
Female
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Hematopoiesis*
Hemoglobins / metabolism
Humans

Substances

Antineoplastic Agents
Colony-Stimulating Factors
Hemoglobins
Granulocyte-Macrophage Colony-Stimulating Factor